Euglena Co., Ltd. (TYO:2931)

Market Cap	44.78B -22.5%
Revenue (ttm)	52.32B +7.8%
Net Income	-173.00M
EPS	-1.26
Shares Out	139.50M
PE Ratio	n/a
Forward PE	84.21
Dividend	2.00 (0.62%)
Ex-Dividend Date	Dec 29, 2025

Volume	89,700
Open	320.00
Previous Close	320.00
Day's Range	319.00 - 321.00
52-Week Range	303.00 - 459.00
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 793
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error